US Patent 6936590 C-aryl glucoside SGLT2 inhibitors and method
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Oct, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+243 characters)
Article
Patent abstract
A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formulaalone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).
Infobox
Is a
Patent Applicant
0
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bruce Ellsworth0
Gang Wu0
Philip M. Sher0
Wei Meng0
William N. Washburn0
Date of Patent
August 30, 2005
0Patent Application Number
102644100
Date Filed
October 4, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6936590 C-aryl glucoside SGLT2 inhibitors and method
Find more entities like US Patent 6936590 C-aryl glucoside SGLT2 inhibitors and method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.